Lipoxin A4 regulation of LPS induced pro-inflammatory responses through inhibiting activation of p38 MAPK and activating Nrf2 pathway
ZHUO Leying1, WU Zhenjie1, YU Xiang2, ZHOU Meixi3, LI Chengye3, OUYANG Jinsheng3, LIN Qibin1, CAI Chang3.
1.The First Clinical Medicine College, Wenzhou Medical University, Wenzhou, 325035; 2.Department of Pulmonary, Yongjia Chinese Medical Hospital, Wenzhou, 325105; 3.Department of Pulmonary, the First Affliated Hospital of Wenzhou Medical University, Wenzhou, 325015
ZHUO Leying,WU Zhenjie,YU Xiang, et al. Lipoxin A4 regulation of LPS induced pro-inflammatory responses through inhibiting activation of p38 MAPK and activating Nrf2 pathway[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2018, 48(6): 418-423.
Abstract:Conclusion: LXA4 may attenuate Objective: To investigate the effect and mechanism of Lipoxin A4 (LXA4) on inflammatory response induced by lipopolysaccharide (LPS) in BEAS-2B cells. Methods: Cultured BEAS-2B cells in logarithmic growth phase were divided into 3 groups: control group (group A, non-treatment), LPS group (group B, incubated with 100 ng/mL LPS for 24 h), LPS+LXA4 treatment group (group C, pretreated with 100 nmol/L LXA4 for 30 min and incubated with 100 ng/mL LPS for 24 h). The mRNA levels of IL-6, IL-1β, heme oxygenase (HO-1) and NAD (P) H: quinone oxidoreductase (NQO-1) were detected by qPCR. The expression of reactive oxygen species (ROS) was detected by flow cytometric analysis. Glutathione (GSH) was measured by a GSH assay kit. Moreover, we investigated the effects of LXA4 on LPS-induced phosphorylation of p38 mitogen-activated protein kinases (MAPK) as well as nuclear translocation and phosphorylation of Nrf2. Results: Compared with group A, the mRNA expressions of IL-6, IL-1β and the level of ROS in group B were significantly increased (P<0.05), while the mRNA level of HO-1 in cells was significantly decreased (P<0.01). Nuclear translocation and phosphorylation of Nrf2 were reduced (P<0.05) and phosphorylation of p38 MAPK was significantly increased (P<0.01) after LPS stimulation. In contrast, in LXA4 treatment group, the above changes were reversed (P<0.05); besides, GSH activity and the mRNA level of NQO-1 were elevated (P<0.05). Conclusion: LXA4 may attenuate Objective: To investigate the effect and mechanism of Lipoxin A4 (LXA4) on inflammatory response induced by lipopolysaccharide (LPS) in BEAS-2B cells. Methods: Cultured BEAS-2B cells in logarithmic growth phase were divided into 3 groups: control group (group A, non-treatment), LPS group (group B, incubated with 100 ng/mL LPS for 24 h), LPS+LXA4 treatment group
[1] 李春来, 张冰缘, 刘再英. 脂氧素在呼吸系统疾病中的研究进展[J]. 中华临床医师杂志(电子版), 2016(11): 197-198.
[2] BORGESON E, JOHNSON A M, LEE Y S, et al. Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease[J]. Cell Metab, 2015, 22 (1): 125-137.
[3] KE Y, ZEBDA N, OSKOLKOVA O, et al. Anti-inflammatory effects of Oxpapc involve endothelial cell-mediated generation of LXA4[J]. Circ Res, 2017, 121(3): 244-257.
[4] QIU Z, ZHOU J, LIU F, et al. Deletion of Shp2 in bronchial epithelial cells impairs IL-25 production in vitro, but has minor influence on asthmatic inflammation in vivo[J]. PLoS One, 2017, 12(5): e0177334.
[5] LEONARDI S, VITALITI G, MARSEGLIA G L, et al. Function of the airway epithelium in asthma[J]. J Biol Regul Homeost Agents, 2012, 26(1 Suppl): S41-48.
[6] DUVALL M G, BARNIG C, CERNADAS M, et al. Natural killer cell-mediated inflammation resolution is disabled in severe asthma[J]. Sci Immunol, 2017, 2(9): eaam5446.
[7] HEIJINK I H, NAWIJN M C, HACKETT T L. Airway epithelial barrier function regulates the pathogenesis of allergic asthma[J]. Clin Exp Allergy, 2014, 44(5): 620-630.
[8] KAUR D, BRIGHTLING C. OX40/OX40 ligand interactions in T-cell regulation and asthma[J]. Chest, 2012, 141(2): 494-499.
[9] RAJU K R, KUMAR M N, GUPTA S, et al. 5-Aminosalicylic acid attenuates allergen-induced airway inflammation and oxidative stress in asthma[J]. Pulm Pharmacol Ther, 2014, 29(2): 209-216.
[10] LI H, YIN J, LI L, et al. Isoflurane postconditioning reduces ischemia-induced nuclear factor-κB activation and interleukin 1β production to provide neuroprotection in rats and mice[J]. Neurobiol Dis, 2013, 54: 216-224.
[11] KURE I, NISHIUMI S, NISHITANI Y, et al. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappa B activation[J]. J Pharmacol Exp Ther, 2010, 332(2): 541-548.
[12] KAVIARASAN K, JITHU M, ARIF M M, et al. Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopa-thy[J]. Metabolism, 2015, 64(9): 958-966.
[13] GUAN S P, TEE W, NG D S, et al. Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity[J]. Br J Pharmacol, 2013, 168(7): 1707-1718.
[14] PARK J, KWAK C H, HA S H, et al. Ganglioside GM3 suppresses lipopolysaccharide-induced inflammatory responses in rAW 264.7 macrophage cells through NF-kappaB, AP-1, and MAPKs signaling[J]. J Cell Biochem, 2018, 119(1): 1173-1182.
[15] QI W, LI H, CAI X H, et al. Lipoxin A4 activates alveolar epithelial sodium channel gamma via the microRNA-21/PTEN/AKT pathway in lipopolysaccharide-induced inflammatory lung injury[J]. Lab Invest, 2015, 95(11): 1258-1268.
[16] DOUILLET C D, ROBINSON W P, MILANO P M, et al. Nucleotides induce IL-6 release from human airway epithelia via P2Y2 and p38 MAPK-dependent pathways[J]. Am J Physiol Lung Cell Mol Physiol, 2006, 291(4): L734-746.
[17] FURUSAWA J, MORO K, MOTOMURA Y, et al. Critical role of p38 and GATA3 in natural helper cell function[J]. J Immunol, 2013, 191(4): 1818-1826.
[18] JIN M, KIM S R, YOON S J, et al. Suppressive effects of fructus of Magnolia denudata on IL-4 and IL-13 expression in T cells[J]. In Vitro Cell Dev Biol Anim, 2013, 49(10): 805-814.
[19] 周昱, 吴升华, 陈筱青, 等. LXA4通过p38MAPK/Nrf2信号通路诱导H9c2心肌细胞HO-1高表达[J]. 南京医科大学学报(自然科学版), 2012, 32(11): 1493-1498.
[20] WANG Y P, WU Y, LI L Y, et al. Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-kappaB and MAPKs in BV-2 microglial cells[J]. J Neuroinflammation, 2011, 8: 95.
[21] SMIRNOVA N A, HASKEW-LAYTON R E, BASSO M,
et al. Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators[J]. Chem Biol, 2011, 18(6): 752-765.
[22] PARK J, MIN J S, KIM B, et al. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-kappaB pathways[J].Neurosci Lett, 2015, 584: 191-196.
[23] YANG H L, LIN M W, KORIVI M, et al. Coenzyme Q0 regulates NFkappaB/AP-1 activation and enhances Nrf2 stabilization in attenuation of LPS-induced inflammation and redox imbalance: Evidence from in vitro and in vivo studies [J]. Biochim Biophys Acta, 2016, 1859(2): 246-261.
[24] FREDENBURGH L E, PERRELLA M A, MITSIALIS S A. The role of heme oxygenase-1 in pulmonary disease[J]. Am J Respir Cell Mol Biol, 2007, 36(2): 158-165.
[25] KIM J, CHA Y N, SURH Y J. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders[J]. Mutat Res, 2010, 690(1-2): 12-23.